Andrey N. Belousov, PhD, DM, Professor is a Ukrainian medical scientist and pioneer in nanotechnology, who developed the world’s first biocompatible nanomedical drugs “Micromage-B, MCS-B"and “ICNB,” introduced into clinical practice in 1998. His work established a translational model linking fundamental biophysics with clinical medicine, with applications in detoxification, hemocorrection, and tissue protection. He has authored more than 370 scientific publications, holds 9 patents, and leads the Laboratory of Applied Nanotechnologies at Kharkiv National Medical University, Ukraine. His research focuses on nanomedicine, critical care pharmacology, blood rheology correction, and the clinical application of nanostructured materials in personalized and minimally invasive therapies.